PERSONLIGT
1. Reservelæge, PhD
Esben Thyssen Vestergaard
Børneafdelingen Herning Sygehus
Gl. Landevej 61
Dk-7400 Herning
TLF.: 7843 0000
Medicinsk Forskningslaboratorium
Aarhus Universitetshospital
Nørrebrogade 44
Bygning 3
Dk-8000 Aarhus C
TLF.: 7846 1631
E-MAIL: etv@dadlnet.dk

EKSAMINER
• PhD i Medicin, Det Sundhedsvidenskabelige Fakultet, Aarhus Universitet, 16/4 – 2008 med titlen ”Clinical aspects of ghrelin: Pharmacokinetics and metabolic effects”
• Cand. med. Aarhus Universitet 1999
• Logik (filosofi) 1990, Rhode Island Community College, USA
• Matematisk-kemisk student 1990, Aarhus Katedralskole

KLINISKE ANSÆTTELSER
• 1/3 2011 – : Hoveduddannelsesreservelæge på Børneafdelingen Regionshospitalet Herning
• 1/3 2009 – 28/2 2011: Hoveduddannelsesreservelæge på Børneafdelingen Århus Universitetshospi-tal Skejby
• 1/2 2008 – 28/2 2009: Introduktionsreservelæge på Klinisk Fysiologisk og Nuklearmedicinsk Afde-ling, Århus Sygehus Nørrebrogade og Århus Universitetshospital Skejby
• 1/9 – 30/9 2004: Reservelæge på Medicinsk Afdeling M, Århus Sygehus
• 1/9 2003 – 30/4 2004: Reservelæge på Pædiatrisk Afdeling, Randers Centralsygehus
• 1/8 2002 – 31/08 2003: Introduktionsstilling i Børne- og Ungdomspsykiatri, i C-amb (Det almene skolebørnsambulatorium), Børne- og Ungdomspsykiatrisk Hospital i Risskov
• 1/2 – 31/7 2002: Reservelæge på Lungemedicinsk Afdeling, Århus Sygehus
• 1/2 2001 – 31/1 2002: Introduktionsstilling i pædiatri på Børneafdelingen Viborg Sygehus
• 1/8 2000 – 31/1 2001: Praksisreservelæge
• 1/2 – 31/7 2000: Turnus på Medicinsk Afdeling, Nykøbing/Thisted Sygehus
• 1/8 1999 – 31/1 2000: Turnus på Ortopædkirurgisk Afdeling, Nykøbing/Thisted Sygehus

VIDENSKABELIGE ANSÆTTELSER
• 1/3 2012 – Postdoc, Aarhus Universitet, Institut for Klinisk Medicin
• 1/10 – 30/11 2008: Klinisk assistent, Aarhus Universitet, Klinisk Institut, Medicinsk Afdeling M, Århus Sygehus
• 15/1 – 31/1 2008: Klinisk assistent, Aarhus Universitet, Klinisk Institut, Medicinsk Afdeling M, Århus Sygehus
• 1/1 2006 – 14/1 2008: PhD-stipendiat, Aarhus Universitet, Det Sundhedsvidenskabelige Fakultet
• 1/1 2005 – 14/1 2008: PhD-studerende ved Det Sundhedsvidenskabelige Fakultet, Aarhus Univer-sitet
• 1/5 2004 – 31/12 2005: Klinisk assistent, Aarhus Universitet, Klinisk Institut, Medicinsk Afdeling M, Århus Sygehus. Orlov september 2004 pga. reservelægestilling på den kliniske afdeling samme sted

VIDENSKABELIG PRODUKTION
Originalartikler
• Thalia Marie Blicher, Esben Thyssen Vestergaard og Kim Peder Dalhoff. Det kliniske forløb ved valproatforgiftning hos en treårig. Ugeskr Læger; 2012;174(17):11651
• Thomas Krusenstjerna-Hafstrøm, Esben Thyssen Vestergaard, Mads Buhl, Roni Nielsen, Berthil F. Clasen, Søren Nielsen, Niels Møller, Steen B. Pedersen, and Jens Otto Lunde Jørgensen. Acute Peripheral Metabolic Effects of Intraarterial Leg Infusion of Somatostatin in Healthy Young Men. J Clin Endocrinol Metab 2011; Epub ahead og print2
• Jakob Gjedsted, Mads Buhl, Soren Nielsen, Ole Schmitz, Esben Thyssen Vestergaard, Else Ton-nesen, and Niels Moller. Effects of adrenaline on lactate, glucose, lipid and protein metabolism in the placebo controlled bilaterally perfused human leg. Acta Physiol (Oxf). 2011 Apr 19. Epud ehead of print3
• Esben Thyssen Vestergaard, Mads Buhl, Jakob Gjedsted, Michael Madsen, Niels Jessen, Soren Nielsen, Bruce D. Gaylinn, Jianhua Liu, Michael O. Thorner, Niels Moller, and Jens Otto Lunde Jorgensen. Acute Peripheral Metabolic Effects of Intra-arterial Ghrelin Infusion in Healthy Young Men. J Clin Endocrinol Metab. November 17, 2010 2010:jc.2010-19954
• Esben Thyssen Vestergaard, Lars Christian Gormsen, Niels Jessen, Sten Lund, Troels Krarup Hansen, Niels Møller, Jens Otto Lunde Jørgensen. Ghrelin infusion in humans induces acute insu-lin resistance and lipolysis independent of GH-signaling. Diabetes 2008 Dec;57(12):3205-105
• Esben Thyssen Vestergaard, Christian Born Djurhuus, Jakob Gjedsted, Søren Nielsen, Niels Møller, Jens Juul Holst, Jens Otto Lunde Jørgensen, Ole Schmitz. Acute effects of ghrelin admini-stration on glucose and lipid metabolism. J Clin Endocrinol Metab 2008; 93(2):438-446
• Esben Thyssen Vestergaard, Niels Holmark Andersen, Troels Krarup Hansen, Lars Melholt Rasmussen, Niels Møller, Keld Sorensen, Erik Sloth, Jens Otto Lunde Jørgensen. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. American Journal of Physiology – Heart and Circulatory Physiology. 2007; 293: H3020-H30267
• Esben Thyssen Vestergaard, Troels Krarup Hansen, Lars Christian Gormsen, Preben Jakobsen, Niels Møller, Jens Sandahl Christiansen, Jens Otto Lunde Jørgensen. Constant intravenous ghrelin infusion in healthy young men: Clinical pharmacokinetics and metabolic effects. American Journal of Physiology – Endocrinology and Metabolism 2007; 292: E1829-E18368
• Esben Thyssen Vestergaard, Rolf Dall, Kai HW Lange, Michael Kjær, Jens Sandahl Christian-sen, Jens Otto Lunde Jørgensen. The Ghrelin Response to Exercise Before and After GH Admini-stration. J Clin Endocrinol Metab 2007; Jan;92(1):297-3039
• Esben Thyssen Vestergaard, Troels Krarup Hansen, Steen Nielsen, Niels Møller, Jens Sandahl Christiansen, and Jens Otto Lunde Jørgensen. Effects of growth hormone replacement therapy in adults on serum levels of leptin and ghrelin: The role of lipolysis. European Journal of Endocrinol-ogy; 2005; 153: 545-549. Selected for the European Federation of Endocrine Societies news alert under the heading "What's hot in EJE?"10
• Esben Thyssen Vestergaard, Shelagh Gwendolen Powell & Merete Juul Sørensen. Klinefelters Syndrom og depression. Kasuistik. Ugeskrift for Læger. 2004; Nov 22;166(48):4380 – 111
• Niels Ejskjaer, Esben Thyssen Vestergaard, Per M Hellström, Lars Christian Gormsen, Sten Madsbad, Jan Lysgård Madsen, Thorbjørn A Jensen, John C Pezzullo, Jens Sandahl Christiansen, Laura Shaughnessy, Gordana Kosutic. Clinical Trial: Ghrelin receptor agonist (TZP-101) acceler-ates gastric emptying in adults with diabetes and symptomatic gastroparesis. Alimentary Pharma-cology and Therapeutics. EPUB 26 February 200912
• Esben Sondergaard, Lars C. Gormsen, Birgitte Nellemann, Esben Thyssen Vestergaard, Jens S. Christiansen, and Soren Nielsen. Visceral fat mass is a strong predictor of circulating ghrelin levels in premenopausal women. European Journal of Endocrinology; 2008 EPUB13
• Lars C. Gormsen, Charlotte Nielsen, Jakob Gjedsted, Signe Gjedde, Esben Thyssen Vestergaard, Jens S. Christiansen, Jens Otto Jørgensen, Niels Møller. Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans. Clin Endocrinol (Oxf); 2007; May;66(5):641-514
• Lars C Gormsen, Jakob Gjedsted, Signe Gjedde, Esben Thyssen Vestergaard, Jens S Christian-sen, Jens Otto Jørgensen, Søren Nielsen, and Niels Møller. Free fatty acids decrease circulating ghrelin concentrations in humans. European Journal of Endocrinology; 2006; 154: 667-67315
• Jens Otto Lunde Jørgensen, Niels Jessen, Sten B Pedersen, Esben Vestergaard, Lars Gormsen, Sten Lund and Nils Billestrup. Growth Hormone Receptor Signaling in Skeletal Muscle and Adi-pose Tissue in Human Subjects Following Exposure to an Intravenous GH Bolus. American Jour-nal of Physiology – Endocrinology and Metabolism 2006; 291: 899-90516
• Signe Gjedde, Esben Thyssen Vestergaard, Lars Christian Gormsen, Anne Lene Dalkjær Riis, Jørgen Rungby, Niels Møller, Jørgen Weeke, Jens Otto Lunde Jørgensen. Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-thyroxin treatment. J Clin Endocri-nol Metab 2008; Jun;93(6):2277-8017
• Tina Parkner, Torben Laursen, Esben Thyssen Vestergaard, Helle Hartvig, Jørgen S. Smede-gaard, Torsten Lauritzen, and Jens S. Christiansen. CSII improved Insulin and Glucose Profiles as compared to Injection of a Long-acting Insulin in Type 2 Diabetes. Diabetic Medicine 2008; 25(5): 585-9118
Oversigtsartikler
• Esben Thyssen Vestergaard and Jens Otto Lunde Jorgensen. Role of ghrelin in growth hor-mone-deficient patients. Invited review. Expert Review of Endocrinology & Metabolism. 2006;1(3):343-5119
• Jens Otto Lunde Jørgensen, Morten Krag, Niels Jessen, Helene Nørrelund, Esben Thyssen Ve-stergaard, Niels Møller, Jens Sandahl Christiansen. Growth hormone and glucose homeostasis. Horm Res. 2004;62 Suppl 3:51-520
• Jens Otto Lunde Jørgensen, Esben Thyssen Vestergaard, Lars Gormsen, Niels Jessen, Helene Nørrelund, Jens Sandahl Christiansen, and Niels Møller. Metabolic consequences of GH deficiency. J. Endocrinol. Invest. 28(Suppl. to no. 5): 47-51, 200521
• Jens Otto Lunde Jørgensen, Jens Juel Christensen, Esben Thyssen Vestergaard, Sanne Fisker, Per Ovesen, Jens Sandahl Christiansen. Sex Steroids and the Growth Hormone/Insulin-Like Growth Factor-I Axis in Adults. Horm Res 2005;64(suppl 2):37–4022
• Jens Otto Lunde Jørgensen, Esben Thyssen Vestergaard, Morten Krag, Charlotte Nielsen, Loui-se Møller, Lars Gormsen, Niels Jessen. Skeletal muscle as a metabolic target for growth hor-mone.Horm.Res. 2006;66 Suppl 1:22-523


ORALE PRÆSENTATIONER VED INTERNATIONALE KONGRESSER
• Metabolic effects of ghrelin. Growth Hormone Physiology & Pathophysiology - Master Class Course. August 26 and 27, 2010 Department of Endocrinology in Aarhus/Denmark
• Metabolic effects of ghrelin. Growth Hormone Physiology & Pathophysiology - Master Class Course. August 27 and 28, 2009 Department of Endocrinology in Aarhus/Denmark
• Peripheral Effects of Ghrelin. The Second Nordic Neuroendocrine Symposium, March 12, 2009 in Copenhagen, Denmark
• Ghrelin-Induced GH Release Translates into GH Signaling in Skeletal Muscle: In Vivo Studies in Human Subjects. The Endocrine Society’s 89th Annual Meeting, June 2 – 5 2007 in Toronto, Can-ada
• The Pharmacokinetics of Ghrelin. The Third International Congress of the GRS and the IGF Soci-ety, 11 – 15/11 2006, Kobe, Japan. Awarded with a travel grant for outstanding abstract
• Normalization of Insulin Sensitivity Through Pharmacological Antilipolysis Unmasks a Direct Sup-pressive Effect of GH on Circulating Ghrelin Levels. Fifth International Symposium On GHS: Ghrelin And Its Analogues Across The Lifespan. Portofino, Italia, 28 – 31/10 2004. Selected as “hot topic” presentation

POSTER PRÆSENTATIONER
• Peripheral metabolic effects of intra-arterial somatostatin infusion in healthy young men, The En-docrine Society’s 92nd Annual Meeting, June 19 – 22 2010 San Diego, USA
• Peripheral metabolic effects of intra-arterial ghrelin infusion in healthy young men, The Endocrine Society’s 91st Annual Meeting, June 10 – 13 2009 Washington D.C. USA
• Visceral fat mass is a strong predictor of circulating ghrelin levels in human. PhD Day 16/1 2009, University of Aarhus
• The acylated fraction of ghrelin is enhanced by growth hormone receptor receptor blockade in the fasting state. PhD Day 16/1 2009, University of Aarhus
• Visceral fat mass, not total fat mass or body mass index, is the strongest predictor of circulating ghrelin levels in human. The Fourth International Congress of the GRS and the IGF Society, Sep-tember 16 – 20 2008 Genoa, Italy
• Ghrelin agonist (TZP-101) accelerates gastric emptying independently of the presence of auto-nomic neuropathy in patients with diabetic gastroparesis. 18th Annual Meeting of the Diabetic Neuropathy Study Group of the EASD NEURODIAB XVIII, September 4 – 7 2008, Orvieto, It-aly
• No effect of acute ghrelin infusion or GH administration on serum levels of retinol-binding protein 4. The Endocrine Society’s 90th Annual Meeting, June 15 – 18 2008 San Francisco, USA
• Serum ghrelin levels are increased in hypothyroid patient and become normalized after L-thyroxin treatment. ECE2008 3 – 7/5 2008 Berlin, Germany
• Ghrelin-induced GH release translates into GH signaling in skeletal muscle – in vivo studies in hu-man subjects. PhD Day 18/1 2008, University of Aarhus
• Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-thyroxin treatment: Evidence from a clinical controlled human study. PhD Day 18/1 2008, University of Aarhus
• Intravenous constant ghrelin infusion in healthy young men: Sustained cardiovascular effects of su-praphysiological ghrelin levels. ECE2007 28/4 – 2/5 2007 Budapest, Hungary
• Effects of physiological bell-shaped elevations of free fatty acids on glucose metabolism and insulin sensitivity in humans. ECE2007, 28/4 – 2/5 2007 Budapest, Hungary
• The Pharmacokinetics of Ghrelin. PhD Day 12/1 2007, University of Aarhus. Awarded a poster prize by the Faculty of Health Sciences, University of Aarhus
• Free fatty acid infusion acutely and reversibly suppresses serum ghrelin levels, The Third Interna-tional Congress of the GRS and the IGF Society, 11 – 15/11 2006, Kobe, Japan
• The Ghrelin Response to Exercise Before and After GH Administration. PhD Day, University of Aarhus 13/1 2006
• The Ghrelin Response to Exercise Before and After GH Administration. ECE2005, 3 – 7/9 2005, Göteborg
• Growth Hormone Signaling in Human Subjects: Acute Activation of STAT5 in Skeletal Muscle Bi-opsies Following Exposure to an Intravenous GH Bolus. The Endocrine Society’s 87th Annual Meeting, 4 – 7/6 2005, San Diego, USA
• Normalization of Insulin Sensitivity Through Pharmacological Antilipolysis Unmasks a Direct Sup-pressive Effect of GH on Circulating Ghrelin Levels. Fifth International Symposium On GHS: Ghrelin And Its Analogues Across The Lifespan. Portofino, Italia, 28 – 31/10 2004


KONGRESDELTAGELSE
• EliteForsk Konference 2012. 9. februar 2012. Ny Carlsberg Glyptoteks festsal, København
• Dansk Pædiatrisk Selskabs Årsmøde. Maj 2011. Kolding Fjord
• Metabolic effects of ghrelin. Growth Hormone Physiology & Pathophysiology - Master Class Course. August 26 an 27, 2010 Department of Endocrinology in Aarhus/Denmark
• ESPE Science School including the NICHe Conference “Child Health and Signal Transduction”, May 20-24, 2010 in Varberg m Sweden
• The Second Nordic Neuroendocrine Symposium, March 12, 2009 in Copenhagen, Denmark
• The Endocrine Society’s 90th Annual Meeting, June 15 – 18 2008 San Francisco, USA
• The Endocrine Society’s 89th Annual Meeting, June 2 – 5 2007 Toronto, Canada
• The 9th European Congress of Endocrinology ECE2007 28 April – 2 May 2007 Budapest Hungary
• The Third International Congress of the GRS and the IGF Society, 11 – 15/11 2006, Kobe, Japan
• European Congress of Endocrinology ECE2005 3 – 7 September 2005 Göteborg, Sweden
• Fifth International Symposium On GHS: Ghrelin And Its Analogues Across The Lifespan, Porto-fino, Italia, 28 – 31/10 2004
• EAACI, The XXI Congress of the European Academy of Allergology and Clinical Immunology, Naples, Italy 1 – 5 June 2002

EDITORIAL BOARD MEMBERSHIP
• Member of the of World Journal of Diabetes (WJD) Editorial Board, 9/10 2009 –

CHAIRMANSHIP
• Chairman at Aarhus University PhD day January 15 2010

REVIEW AF VIDENSKABELIGE ARTIKLER
Deltager løbende som reviewer af artikler for følgende internationale videnskabelige tidsskrifter: The Journal of Clinical Endocrinology and Metabolism, Endocrinology, Hormone and Metabolic Research, Growth Hormone & IGF Research, European Journal of Endocrinology, Scandinavian Journal of Medi-cine and Science in Sports, Nutrition, Metabolism & Cardiovascular Diseases, Peptides, Clinical and ex-perimentel medicine, The American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, Diabetologia

KONGRES REVIEWS
• Reviewer for the 50th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) 2011 in Glasgow, United Kingdom
• Reviewer for the 51st Annual Meeting of the European Society for Paediatric Endocrinology (ESPE) 2012 in Leipzig, Germany

TILDELING AF STIPENDIER
• December 2011: Tildelt Sapere Aude: DFF-Ung Eliteforsker
• July 2011: Tildelt postdoc stipendium fra Det Frie Forskningsråd Sundhed og Sygdom
• Januar 2011: Tildelt Ipsens Vækststipendium
• Januar 2010: Travel grant from ESPE to participate in ESPE Science School including the NICHe Conference “Child Health and Signal Transduction”
• Marts 2009: Dir. Kurt Bønnelyckes Fond
• December 2008: Forskningsapparaturfonden ved Århus Universitetshospital
• November 2008: Forsknings- og Innovationsstyrelsen, Forskningsrådet for Sundhed og Sygdom
• Maj 2008: Århus Sygehus mhp. kongresdeltagelse The Endocrine Society’s 90th Annual Meeting, June 15 – 18 2008 San Francisco, USA
• Marts 2008: Grosserer L.F. Foghts Fond
• December 2007: AP Møller Fonden
• November 2007: Novo Nordisk Fonden
• November 2007: Forsknings- og Innovationsstyrelsen, Forskningsrådet for Sundhed og Sygdom
• Februar 2007: Det Sundhedsvidenskabelige Fakultets rejsekonto til Endocrine Society’s 89th An-nual Meeting i Toronto 2. til 5. juni 2007
• Januar 2007: Dansk Endokrinologisk Selskab
• November 2006: Det Sundhedsvidenskabelige Fakultets rejsekonto
• November 2005: Novo Nordisk Fonden
• December 2004: AP Møller Fonden
• Maj 2004: Århus Universitetshospitals Forskningsinitiativ

360 GRADERS EVALUERING
• Evaluering Børneafdelingen Skejby 08.12.2010: Performance score, overall: 89% sv.t. høj perfor-mance. Høj performance er top-niveau. Kompetencerne er højt udviklet, og der er et godt samspil mellem alle kompetenceområder




UNDERVISNING
Jeg har siden studietiden undervist i: Anatomi, Aarhus Universitet; pædiatri, Færdighedslaboratoriet, Ek-saminatoriske Klinikker – teoretisk kursus for medicinstuderend og på Aarhus Universitet Health: PhD-kursus

KURSER
• Praktisk Lungemedicin, DADL, 12/4 2000
• Praktisk Elektrokardiologi, DADL, 27/4 2000
• Praktisk kardiovaskulær Farmakologi, DADL, 3/5 2000
• Antibiotika – god klinisk anvendelse i almen praksis, IRF, 26/10 2000
• Praktisk mikrobiologi og antibiotikaterapi, DADL, 12/6 2001
• Voksenpædagogisk Kursus, Viborg Sygehus, 17 – 19/12 2001
• Spiseforstyrrelser, LKF Århus, 4/10 2002
• Konflikthåndtering for Læger, Udd.afd. Århus Amt, Psykiatrien, 9 – 11/10 2002
• Rationel brug af psykofarmaka, IRF, 5/3 2003
• PubMed Grundkursus, Psykiatrisk Forskningsbibliotek, 20/5 2003
• Forskning – hvordan kommer jeg rationelt i gang? DADL, 27/10 2003
• PhD-forberedelseskursus, j. nr. 108/01, 20/2 og 27/2 2004, Aarhus Universitet, 1,0 ECTS point
• Pituitary Explorer Educational Programme. Novo Nordisk, Hvidøre, 31/5 – 3/6 2004. 1,5 ECTS point
• Præsentation af Forskningsdata med Powerpoint, j. nr. 95/11, 17/11 2004, Aarhus Universitet, 0,5 ECTS point
• Grundkursus i Sundhedsvidenskabelig Forskning, j. nr. 1000/05, 24 – 26/1 2005, Aarhus Universi-tet, 1,5 ECTS point
• Postgraduate course in “Basic Biostatistics, j. nr. 1050/03, 2/2 9/3 2005, Aarhus Universitet, 4,0 ECTS point
• Grafisk fremstilling af kvantitative videnskabelige data, j.nr. 32/19, 7 – 18/3 2005, Aarhus Universi-tet, 2,0 ECTS point
• Microsoft Excel i biomedicinsk forskning, j.nr. 113/01, 12 – 19/4 2005, Aarhus Universitet, 0,5 ECTS point
• Postgraduate course in Analysis Of Variance and Repeated Measurements, j.nr 1051/-, 26/4 – 8/6 2005, Aarhus Universitet, 3,5 ECTS point
• Engelsk medicinsk sprogbrug I Grundkursus, j.nr. 46/33, 1 – 29/9 2005, Aarhus Universitet, 2,5 ECTS point
• Klinisk vurdering af insulinresistens og andre stofskifteparametre, j.nr. 112/01, 10 – 11/10 2005, Aarhus Universitet, 1,0 ECTS point
• Målrettet kursus i biomedicinske metoder og begreber, j.nr. 1001/02, 7 – 9/11 2005, Aarhus Uni-versitet, 1,5 ECTS point
• Målrettet grundkursus i Klinisk Forskning, j.nr. 1002/02, 28/11 – 1/12 2005, Aarhus Universitet, 2,0 ECTS point
• Pressekursus, j.nr. 109/05, 13 – 28/3 2006, Aarhus Universitet, 0,5 ECTS point
• Postgraduate course in Linear and logistic regression, j. nr. 1053/04, 2 – 19/5 2006, Aarhus Univer-sitet, 2,0 ECTS point
• Cytokine Receptors as Therapeutic Targets, 22 – 24/8 2006, Danish Clinical Intervention Research Academy, 2,5 ECTS point
• Molecular Mechanisms in the Metabolic Syndrome, 29/10 – 1/11 2007, DaCRA og Syddansk Uni-versitet, 2,0 ECTS point
• Eftermiddagskursus i vejledning – for vejledere, 23/10 2008, Det Sundhedsvidenskabelige Fakultet Aarhus Universitet
• Generelt kursus i vejledning, 3-4/2 + 16/3 2009, Sundhedsfagligt Videnscenter
• LAS 1, 12-13/2009, Region Midtjylland, Koldkærgaard Konferencecenter
• Hjerte-lunge-redning børn, niveau 3, 21/8 2009, Århus Universitetshospital, Skejby
• LAS 2, 29/9 – 1/10 og 9/11 2009, Region Midtjylland, Hotel Scandic Silkeborg

PÆDIATRISKE HOVEDUDDANNELSESKURSER
• Gastroenterologi, 21-24/11 2011, Kolding Sygehus
• Børnespykiatri, 30-31/5 og 1/6 2011, Hovedstaden Psykiatri
• Hæmatologi, onkologi, immunologi, infektionsmedicin og rheumatologi, 25 – 26/2010 OUH og 6 – 7/2010 Århus Universitetshospital Skejby
• Akut Pædiatri, speciallægekursus, 7 – 8/6 2010, Århus Universitetshospital Skejby
• Endokrinologi, speciallægekursus, 23 – 25/11 2009, Rigshospitalet
• Pulmonologi, speciallægekursus, 26 – 29/10 2009, Panum Instituttet
• Klinisk genetik, speciallægekursus, 24 – 25/8 2009, Rigshospitalet
• Neonatologi, speciallægekursus, 9 – 12/3 2009, Århus Universitetshospital Skejby

MEDLEMSKAB AF VIDENSKABELIGE SELSKABER
• Medlem af The Endocrine Society, marts 2012 –
• Medlem af European Society for Paediatric Endocrinology (ESPE), november 2010 –
• Medlem af Dansk Pædiatrisk Selskab (DPS), 2010 –
• Medlem af American Physiological Society 14. marts 2007 –
• Medlem af European NeuroEndocrine Association 12. april 2012 –

PUBLIKATIONSLISTE

1. Blicher TM VE, Dalhoff KP. Det kliniske forløb ved valproatforgiftning hos en treårig. Ugeskr Læger. April 23 2012 2012;174(17):2.
2. Krusenstjerna-Hafstr√∏m T, Vestergaard ET, Buhl M, et al. Acute Peripheral Metabolic Effects of Intraarterial Leg Infusion of Somatostatin in Healthy Young Men. Journal of Clinical Endocrinology & Metabolism. June 1, 2011 2011.
3. Gjedsted J, Buhl M, Nielsen S, et al. Effects of adrenaline on lactate, glucose, lipid and protein metabolism in the placebo controlled bilaterally perfused human leg. Acta Physiologica. 2011:no-no.
4. Vestergaard ET, Buhl M, Gjedsted J, et al. Acute Peripheral Metabolic Effects of Intraarterial Ghrelin Infusion in Healthy Young Men. J Clin Endocrinol Metab. November 17, 2010 2010:jc.2010-1995.
5. Vestergaard ET, Gormsen LC, Jessen N, et al. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of GH-signaling. Diabetes. 2008.
6. Vestergaard ET, Djurhuus CB, Gjedsted J, et al. Acute Effects of Ghrelin Administration on Glucose and Lipid Metabolism. Journal of Clinical Endocrinology Metabolism. 2008;93(2):438-444.
7. Vestergaard ET, Andersen NH, Hansen TK, et al. Cardiovascular effects of intravenous ghrelin infusion in healthy young men. AJP - Heart and Circulatory Physiology. 2007;293(5):H3020-H3026.
8. Vestergaard ET, Hansen TK, Gormsen LC, et al. Constant intravenous ghrelin infusion in healthy young men: Clinical pharmacokinetics and metabolic effects. Am.J Physiol Endocrinol Metab. 2007;292(6):E1829-E1836.
9. Vestergaard ET, Dall R, Lange KHW, Kjaer M, Christiansen JS, Jorgensen JOL. The Ghrelin Response to Exercise Before and After GH Administration. Journal of Clinical Endocrinology Metabolism. 2007:jc.
10. Vestergaard ET, Hansen TK, Nielsen S, Moller N, Christiansen JS, Jorgensen JO. Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. Eur.J Endocrinol. 2005;153(4):545-549.
11. Vestergaard ET, Powell SG, Sorensen MJ. [Klinefelter's syndrome and depression]. Ugeskr.Laeger. 2004;166(48):4380-4381.
12. Ejskjaer N, Vestergaard ET, Hellstrom PM, et al. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis. Aliment.Pharmacol Ther. 2009;29(11):1179-1187.
13. Sondergaard E, Gormsen L, Nellemann B, Vestergaard E, Christiansen J, Nielsen S. Visceral fat mass is a strong predictor of circulating ghrelin levels in premenopausal women. Acta Endocrinologica. 2008:EJE-08.
14. Gormsen LC, Nielsen C, Gjedsted J, et al. Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans. Clinical Endocrinology. 2007;0(0):???-???
15. Gormsen LC, Gjedsted J, Gjedde S, et al. Free fatty acids decrease circulating ghrelin concentrations in humans. Eur.J Endocrinol. 2006;154(5):667-673.
16. Jorgensen JO, Jessen N, Pedersen SB, et al. Growth Hormone Receptor Signaling in Skeletal Muscle and Adipose Tissue in Human Subjects Following Exposure to an Intravenous GH Bolus. Am.J Physiol Endocrinol Metab. 2006;291:E899-E905.
17. Gjedde S, Vestergaard ET, Gormsen LC, et al. Serum ghrelin levels are increased in hypothyroid patients and become normalized by L-thyroxin treatment. Journal of Clinical Endocrinology Metabolism. 2008:jc.
18. Parkner T, Laursen T, Vestergaard ET, et al. Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes. Diabet.Med. 2008;25(5):585-591.
19. Vestergaard ET, Jorgensen JOL. Role of ghrelin in growth hormone-deficient patients. Expert Review of Endocrinology & Metabolism. 2006;1(3):343-351.
20. Jorgensen JO, Krag M, Jessen N, et al. Growth hormone and glucose homeostasis. Horm.Res. 2004;62 Suppl 3:51-55.
21. Jorgensen JO, Vestergaard E, Gormsen L, et al. Metabolic consequences of GH deficiency. J Endocrinol Invest. 2005;28(5 Suppl):47-51.
22. Jorgensen JO, Christensen JJ, Vestergaard E, Fisker S, Ovesen P, Christiansen JS. Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults. Horm.Res. 2005;64 Suppl 2:37-40.
23. Jorgensen JO, Vestergaard ET, Krag M, et al. Skeletal muscle as a metabolic target for growth hormone. Horm.Res. 2007;66 Suppl 1:22-25.